Research
Researchers found that pairing a next-generation immunotherapy with standard hormone therapy before surgery may help overcome a long-standing barrier in early-stage prostate cancer treatment.
Latest stories
Research
January 15, 2026
Individualized Medicine
January 14, 2026
Research
December 22, 2025
Gastroenterology
December 17, 2025
Research
December 16, 2025
Research
December 15, 2025
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community